vs
Side-by-side financial comparison of Fabrinet (FN) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.3× Fabrinet). Fabrinet runs the higher net margin — 9.9% vs 4.4%, a 5.5% gap on every dollar of revenue. On growth, Fabrinet posted the faster year-over-year revenue change (35.9% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-5.3M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 24.4%).
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
FN vs ONC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $112.6M | $66.5M |
| Gross Margin | 12.2% | 90.5% |
| Operating Margin | 10.1% | 12.4% |
| Net Margin | 9.9% | 4.4% |
| Revenue YoY | 35.9% | 32.8% |
| Net Profit YoY | 30.0% | 143.8% |
| EPS (diluted) | $3.11 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $978.1M | $1.4B | ||
| Q2 25 | $909.7M | $1.3B | ||
| Q1 25 | $871.8M | $1.1B | ||
| Q4 24 | $833.6M | $1.1B | ||
| Q3 24 | $804.2M | $1.0B | ||
| Q2 24 | $753.3M | $929.2M | ||
| Q1 24 | $731.5M | $751.7M |
| Q4 25 | $112.6M | $66.5M | ||
| Q3 25 | $95.9M | $124.8M | ||
| Q2 25 | $87.2M | $94.3M | ||
| Q1 25 | $81.3M | $1.3M | ||
| Q4 24 | $86.6M | $-151.9M | ||
| Q3 24 | $77.4M | $-121.3M | ||
| Q2 24 | $81.1M | $-120.4M | ||
| Q1 24 | $80.9M | $-251.2M |
| Q4 25 | 12.2% | 90.5% | ||
| Q3 25 | 11.9% | 86.1% | ||
| Q2 25 | 12.2% | 87.5% | ||
| Q1 25 | 11.7% | 85.2% | ||
| Q4 24 | 12.1% | 85.8% | ||
| Q3 24 | 12.3% | 83.0% | ||
| Q2 24 | 12.3% | 85.1% | ||
| Q1 24 | 12.4% | 83.4% |
| Q4 25 | 10.1% | 12.4% | ||
| Q3 25 | 9.6% | 11.5% | ||
| Q2 25 | 9.8% | 6.7% | ||
| Q1 25 | 9.0% | 1.0% | ||
| Q4 24 | 9.5% | -7.0% | ||
| Q3 24 | 9.6% | -12.0% | ||
| Q2 24 | 9.7% | -11.5% | ||
| Q1 24 | 9.7% | -34.8% |
| Q4 25 | 9.9% | 4.4% | ||
| Q3 25 | 9.8% | 8.8% | ||
| Q2 25 | 9.6% | 7.2% | ||
| Q1 25 | 9.3% | 0.1% | ||
| Q4 24 | 10.4% | -13.5% | ||
| Q3 24 | 9.6% | -12.1% | ||
| Q2 24 | 10.8% | -13.0% | ||
| Q1 24 | 11.1% | -33.4% |
| Q4 25 | $3.11 | $0.05 | ||
| Q3 25 | $2.66 | $0.08 | ||
| Q2 25 | $2.41 | $0.06 | ||
| Q1 25 | $2.25 | $0.00 | ||
| Q4 24 | $2.38 | $-0.10 | ||
| Q3 24 | $2.13 | $-0.09 | ||
| Q2 24 | $2.22 | $-0.09 | ||
| Q1 24 | $2.21 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $960.8M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $2.2B | $4.4B |
| Total Assets | $3.3B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $960.8M | $4.5B | ||
| Q3 25 | $968.8M | $4.0B | ||
| Q2 25 | $934.2M | $2.8B | ||
| Q1 25 | $950.7M | $2.5B | ||
| Q4 24 | $934.6M | $2.6B | ||
| Q3 24 | $908.9M | $2.7B | ||
| Q2 24 | $858.6M | $2.6B | ||
| Q1 24 | $794.0M | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.1B | $4.1B | ||
| Q2 25 | $2.0B | $3.8B | ||
| Q1 25 | $1.9B | $3.5B | ||
| Q4 24 | $1.8B | $3.3B | ||
| Q3 24 | $1.8B | $3.4B | ||
| Q2 24 | $1.7B | $3.4B | ||
| Q1 24 | $1.7B | $3.4B |
| Q4 25 | $3.3B | $8.2B | ||
| Q3 25 | $3.0B | $7.6B | ||
| Q2 25 | $2.8B | $6.3B | ||
| Q1 25 | $2.6B | $5.8B | ||
| Q4 24 | $2.5B | $5.9B | ||
| Q3 24 | $2.4B | $5.8B | ||
| Q2 24 | $2.3B | $5.7B | ||
| Q1 24 | $2.2B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.3M | $417.3M |
| Free Cash FlowOCF − Capex | $-5.3M | $379.8M |
| FCF MarginFCF / Revenue | -0.5% | 25.4% |
| Capex IntensityCapex / Revenue | 4.6% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.41× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $102.3M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.3M | $417.3M | ||
| Q3 25 | $102.6M | $402.6M | ||
| Q2 25 | $55.1M | $263.6M | ||
| Q1 25 | $74.2M | $44.1M | ||
| Q4 24 | $115.9M | $75.2M | ||
| Q3 24 | $83.2M | $188.4M | ||
| Q2 24 | $83.1M | $-95.6M | ||
| Q1 24 | $100.9M | $-308.6M |
| Q4 25 | $-5.3M | $379.8M | ||
| Q3 25 | $57.3M | $354.5M | ||
| Q2 25 | $4.7M | $219.8M | ||
| Q1 25 | $45.7M | $-12.3M | ||
| Q4 24 | $94.0M | $-17.3M | ||
| Q3 24 | $62.9M | $54.7M | ||
| Q2 24 | $70.4M | $-205.5M | ||
| Q1 24 | $87.3M | $-465.1M |
| Q4 25 | -0.5% | 25.4% | ||
| Q3 25 | 5.9% | 25.1% | ||
| Q2 25 | 0.5% | 16.7% | ||
| Q1 25 | 5.2% | -1.1% | ||
| Q4 24 | 11.3% | -1.5% | ||
| Q3 24 | 7.8% | 5.5% | ||
| Q2 24 | 9.3% | -22.1% | ||
| Q1 24 | 11.9% | -61.9% |
| Q4 25 | 4.6% | 2.5% | ||
| Q3 25 | 4.6% | 3.4% | ||
| Q2 25 | 5.5% | 3.3% | ||
| Q1 25 | 3.3% | 5.0% | ||
| Q4 24 | 2.6% | 8.2% | ||
| Q3 24 | 2.5% | 13.3% | ||
| Q2 24 | 1.7% | 11.8% | ||
| Q1 24 | 1.9% | 20.8% |
| Q4 25 | 0.41× | 6.28× | ||
| Q3 25 | 1.07× | 3.22× | ||
| Q2 25 | 0.63× | 2.79× | ||
| Q1 25 | 0.91× | 34.71× | ||
| Q4 24 | 1.34× | — | ||
| Q3 24 | 1.07× | — | ||
| Q2 24 | 1.02× | — | ||
| Q1 24 | 1.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
ONC
Segment breakdown not available.
